Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Gabriella Alexandersson von Döbeln"'
Autor:
Halla Sif Ólafsdóttir, Emmy Dalqvist, Eva Onjukka, Fredrik Klevebro, Magnus Nilsson, Giovanna Gagliardi, Gabriella Alexandersson von Döbeln
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 40, Iss , Pp 100610- (2023)
Background: Complications after esophagectomy are common and the possible increase in postoperative complications associated with neoadjuvant chemoradiotherapy is of concern. The aim of our study was to analyze if the addition of radiotherapy to neoa
Externí odkaz:
https://doaj.org/article/89a0d735b54b401d90c2c078d7fa3f65
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-10 (2021)
Abstract Background Common symptoms of oesophageal cancer are dysphagia, pain, and bleeding. These symptoms can be relieved with palliative radiotherapy. The aim of this study was to analyse the outcome of two different palliative radiotherapy schedu
Externí odkaz:
https://doaj.org/article/6672d6874acb40118725dfce98cf91b9
Autor:
Magnus Nilsson, Halla Olafsdottir, Gabriella Alexandersson von Döbeln, Fernanda Villegas, Giovanna Gagliardi, Mats Hellström, Qiao-Li Wang, Hemming Johansson, Val Gebski, Jakob Hedberg, Fredrik Klevebro, Sheraz Markar, Elizabeth Smyth, Pernilla Lagergren, Ghazwan Al-Haidari, Lars Cato Rekstad, Eirik Kjus Aahlin, Bengt Wallner, David Edholm, Jan Johansson, Eva Szabo, John V. Reynolds, CS Pramesh, Naveen Mummudi, Amit Joshi, Lorenzo Ferri, Rebecca KS Wong, Chris O’Callaghan, Jelena Lukovic, Kelvin KW Chan, Trevor Leong, Andrew Barbour, Mark Smithers, Yin Li, Xiaozheng Kang, Feng-Ming Kong, Yin-Kai Chao, Tom Crosby, Christiane Bruns, Hanneke van Laarhoven, Mark van Berge Henegouwen, Richard van Hillegersberg, Riccardo Rosati, Guillaume Piessen, Giovanni de Manzoni, Florian Lordick
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe globally dominant treatment with curative intent for locally advanced esophageal squamous cell carcinoma (ESCC) is neoadjuvant chemoradiotherapy (nCRT) with subsequent esophagectomy. This multimodal treatment leads to around 60% overall
Externí odkaz:
https://doaj.org/article/c303a3a5e5d942c9a1b8efb0a9d35233
Autor:
Eva Onjukka, Claes Mercke, Einar Björgvinsson, Anna Embring, Anders Berglund, Gabriella Alexandersson von Döbeln, Signe Friesland, Giovanna Gagliardi, Clara Lenneby Helleday, Helena Sjödin, Ingmar Lax
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
AimData from a local quality registry are used to model the risk of late xerostomia after radiotherapy for head and neck cancer (HNC), based on dosimetric- and clinical variables. Strengths and weaknesses of using quality registry data are explored.M
Externí odkaz:
https://doaj.org/article/a4c1aa59a7034c27a961031ecebc0fdd
Autor:
Gabriella Alexandersson von Döbeln, Gunnar Wagenius, Eva Holtved, Anne-Birgitte Jacobsen, Magnus Nilsson, Jingru Yu, Lene Baeksgaard
Publikováno v:
Cancer Treatment and Research Communications, Vol 24, Iss , Pp 100187- (2020)
Background: Chemoradiotherapy is standard treatment for localized oesophageal cancer unsuitable for surgery. We aimed to evaluate the efficacy of cetuximab in combination with chemoradiotherapy. Methods: This non-randomised multicentre phase II trial
Externí odkaz:
https://doaj.org/article/49e87bf593ef447999c7d68faeae26d0
Autor:
Halla Olafsdottir, Emmy Dalqvist, Osama Hamida, Eva Onjukka, Fredrik Klevebro, Magnus Nilsson, Giovanna Gagliardi, Gabriella Alexandersson von Döbeln
Publikováno v:
Diseases of the Esophagus. 35
Postoperative complications after esophagectomy are common. Neoadjuvant chemotherapy or chemoradiotherapy in addition to surgery is the standard treatment with curative intent for patients with locally advanced esophageal cancer. The aims of our stud
Autor:
Klara Nilsson, Fredrik Klevebro, Berit Sunde, Ioannis Rouvelas, Mats Lindblad, Eva Szabo, Ingvar Halldestam, Ulrika Smedh, Bengt Wallner, Jan Johansson, David Borg, Gjermund Johnsen, Eirik Kjus Aalin, Hans-Olaf Johannessen, Gabriella Alexandersson von Döbeln, Geir Olav Hjortland, Ghazwan Al-Haidari, Alexander Quaas, Naining Wang, Isabel Bartella, Christiane Bruns, Wolfgang Schröder, Magnus Nilsson
Publikováno v:
Diseases of the Esophagus. 35
Time to surgery after termination of neoadjuvant chemoradiotherapy for esophageal cancer has traditionally been 4–6 weeks. Observational studies have suggested that delay of surgery for up to three months may lead to improved tumor regression and b
Autor:
Claes Mercke, Gun Wickart-Johansson, Helena Sjödin, Pedro Farrajota Neves da Silva, Gabriella Alexandersson von Döbeln, Gregori Margolin, Sara Jonmarker Jaraj, Hanna Carstens, Anders Berglund, Ingmar Lax, Mats Hellström, Lalle Hammarstedt-Nordenvall, Signe Friesland
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2543
The leading cause of death for patients with HPV associated squamous cell carcinoma of the head and neck (SCCHN) after treatment with chemoradiotherapy (CRT) nowadays is peripheral metastasis. This study investigated whether induction chemotherapy (I
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 16, Iss 1, Pp 1-10 (2021)
Radiation Oncology, Vol 16, Iss 1, Pp 1-10 (2021)
BackgroundCommon symptoms of oesophageal cancer are dysphagia, pain, and bleeding. These symptoms can be relieved with palliative radiotherapy. The aim of this study was to analyse the outcome of two different palliative radiotherapy schedules.Method
Autor:
Signe Friesland, Gun Wickart Johansson, Pedro Farrajota Neves da Silva, Gabriella Alexandersson von Döbeln, Sara Jonmarker-Jaraj, Ingmar Lax, Lalle Hammarstedt Nordenvall, Claes Mercke
Publikováno v:
Journal of Clinical Oncology. 40:6074-6074
6074 Background: Patients with HPV associated squamous cell carcinoma of the oropharynx have a favorable outcome with respect to tumor control and overall survival (OS) after treatment with chemoradiotherapy (CRT). The leading cause of death in these